Clinical trial
Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
NCT02908282 is registered in ClinicalTrials.gov with TRB Chemedica AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
- Lead sponsor
- TRB Chemedica AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- July 31, 2018
- Enrollment
- 81 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.